Kidney disease in cardiology

Nephrology Dialysis Transplantation

Volumn 22, Issue 1, 2007, Pages 43-46

  Herzog, Charles A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cardiac troponins; Chronic kidney disease; Contrast nephropathy; Coronary artery bypass surgery; End stage renal disease; Stress echocardiography

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CARVEDILOL; CONTRAST MEDIUM; DOBUTAMINE; IODIXANOL; IOXAGLIC ACID; SODIUM CHLORIDE; TROPONIN T;

ANGIOCARDIOGRAPHY; ARTICLE; CARDIOLOGY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DRUG WITHDRAWAL; GRAFT RECIPIENT; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHROLOGY; NON INVASIVE PROCEDURE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING TEST; STRESS ECHOCARDIOGRAPHY;

CARDIOLOGY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; ECHOCARDIOGRAPHY; HEART DISEASES; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MYOCARDIUM; NEPHROLOGY; RISK; TREATMENT OUTCOME; TROPONIN;

EID: 33846011433     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl739     Document Type: Article

References (17)

1. United States Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and digestive and Kidney Diseases. Bethesda, MD, 2006
2. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kid Dis 2005; 45 [Suppl 3]: S1-S154
3. Cice G, Ferrara L, D'Andrea A et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy. A prospective, placebo-controlled trial. J Am Coll Cardiol 2003; 41: 1438-1444
4. Mallamaci F, Zoccali C, Parlongo S et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002; 40: 68-75
5. deFilippi C, Wasserman S, Rosanio S et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290: 353-359
6. Wallace TW, Abdullah SM, Drazner MH et al. Prevalence and determinants of Troponin T elevation in the general population. Circulation 2006; 113: 1958-1965
7. Sharma R, Pellerin D, Gaze DC et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr 2005; 6: 327-335
8. Sharma R, Gaze DC, Pellerin D et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006; 92: 804-809
9. Herzog CA. How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 2003; 14: 2556-2572
10. Poldermans D, Bax JJ, Schouten O et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart control. J Am Coll Cardiol 2006; 48: 964-969
11. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386
12. McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006; 48: 692-699
13. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295: 2765-2779
14. Jo SH, Youn TJ, Koo BK et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients undergoing renal insufficiency undergoing coronary angiography. The RECOVER Study: A randomized controlled trial. J Am Coll Cardiol 2006; 48: 924-930
15. Cooper WA, O'Brien SM, Thourani VH et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery. Results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113: 1063-1070
16. Hillis GS, Croal BL, Buchan KG et al. Renal function and outcome from coronary artery bypass grafting. Impact on mortality after a 2.3-year follow-up. Circulation 2006; 113: 1056-1062
17. Brown JR, Cochran RP, Dacey LJ et al. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation 2006; 114 [1 Suppl]: I409-I413